Post by Emory University Department of Medicine

Congrats to Luis Nieto, MD, second-year Gastroenterology and Hepatology Fellow, on his recent high-impact publications: 🔸AMA Network Open: "Are Incretin-Based Therapies Associated With Decreased Risk of Alcohol Use Disorder After Bariatric Surgery?" 🔹American Journal of Gastroenterology: "Glucagon-Like Peptide-1 Receptor Agonists Use Does Not Increase the Risk for Acute Pancreatitis and Is Associated With Lower Complications in Patients With Type 2 Diabetes Who Develop Acute Pancreatitis: A Multicenter Analysis." Dr. Nieto's research focuses on the intersection between metabolic disease, obesity, and gastrointestinal disorders, with a particular interest in the effects of incretin-based therapies. 🔗 Visit linktr.ee/emorydeptofmed to read these two publications!